Cargando…

Identification of Prognostic Biomarkers and Molecular Targets Among JAK Family in Breast Cancer

BACKGROUND: Janus kinases (JAKs) are a family of non-receptor tyrosine kinases involved in multiple malignancies. However, clinical values of JAKs as prognostic markers and potential mechanism as molecular targets in breast invasive carcinoma (BC) are not completely clarified. METHODOLOGY: TIMER, UA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Fangteng, Wu, Hengyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813467/ https://www.ncbi.nlm.nih.gov/pubmed/33469338 http://dx.doi.org/10.2147/JIR.S284889

Ejemplares similares

CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets
por: Liu, Fangteng, et al.
Publicado: (2021)

Prognostic Value of Gastrokine-2 (GKN2) and Its Correlation with Tumor-Infiltrating Immune Cells in Lung Cancer and Gastric Cancers
por: Liu, Fangteng, et al.
Publicado: (2020)

Identification of ENO1 as a prognostic biomarker and molecular target among ENOs in bladder cancer
por: Huang, Zhengnan, et al.
Publicado: (2022)

Identification of therapeutic targets and prognostic biomarkers among frizzled family genes in glioma
por: Huang, Ke, et al.
Publicado: (2023)

Identification of CISD1 as a Prognostic Biomarker for Breast Cancer
por: Liu, Xiao, et al.
Publicado: (2022)

Identification of therapeutic targets and prognostic biomarkers from the hnRNP family in invasive breast carcinoma
por: Zhou, Jiawei, et al.
Publicado: (2021)

Prognostic and Predictive Biomarkers in Familial Breast Cancer
por: Deb, Siddhartha, et al.
Publicado: (2023)

Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer
por: Zhang, Tianhao, et al.
Publicado: (2021)

Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer
por: Luan, Hong, et al.
Publicado: (2023)

Evidence of the Prognostic Value of Pretreatment Systemic Inflammation Response Index in Cancer Patients: A Pooled Analysis of 19 Cohort Studies
por: Zhang, Yi, et al.
Publicado: (2020)

Identification and validation of tumor microenvironment-related prognostic biomarkers in breast cancer
por: Zhong, Shanliang, et al.
Publicado: (2021)

Identification of Prognostic Biomarkers Among FAM83 Family Genes in Human Ovarian Cancer Through Bioinformatic Analysis and Experimental Verification
por: Lin, Shaochong, et al.
Publicado: (2021)

Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer
por: Fang, Xuefen, et al.
Publicado: (2022)

Identification of three miRNAs signature as a prognostic biomarker in breast cancer using bioinformatics analysis
por: Sang, Meijie, et al.
Publicado: (2020)

Identification of ZG16B as a prognostic biomarker in breast cancer
por: Lu, Haotian, et al.
Publicado: (2020)

Identification of LIG1 and LIG3 as prognostic biomarkers in breast cancer
por: Sun, Lin, et al.
Publicado: (2021)

Identification of the MMP family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma
por: Liu, Maohua, et al.
Publicado: (2023)

COL4A family: potential prognostic biomarkers and therapeutic targets for gastric cancer
por: Zeng, Xi, et al.
Publicado: (2020)

Identification of Novel Molecular Therapeutic Targets and Their Potential Prognostic Biomarkers Among Kinesin Superfamily of Proteins in Pancreatic Ductal Adenocarcinoma
por: Yang, Yang, et al.
Publicado: (2021)

Identification of prognostic biomarkers for breast cancer brain metastases based on the bioinformatics analysis
por: Wu, Zhuoyi, et al.
Publicado: (2022)

The Molecular Predictive and Prognostic Biomarkers in Metastatic Breast Cancer: The Contribution of Molecular Profiling
por: Verret, Benjamin, et al.
Publicado: (2022)

Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma
por: Ma, Zuyi, et al.
Publicado: (2021)

JAK1 as a prognostic marker and its correlation with immune infiltrates in breast cancer
por: Chen, Bo, et al.
Publicado: (2019)

Identification of Tumor Microenvironment-Related Prognostic Biomarkers in Luminal Breast Cancer
por: Wang, Yanyan, et al.
Publicado: (2020)

Identification of differentially methylated genes as diagnostic and prognostic biomarkers of breast cancer
por: Mao, Xiao-hong, et al.
Publicado: (2021)

Identification of Therapeutic Targets and Prognostic Biomarkers among Genes from the Mediator Complex Family in the Hepatocellular Carcinoma Tumour-Immune Microenvironment
por: Tan, Wei, et al.
Publicado: (2022)

Identification of Spindle and Kinetochore-Associated Family Genes as Therapeutic Targets and Prognostic Biomarkers in Pancreas Ductal Adenocarcinoma Microenvironment
por: Liu, Yi, et al.
Publicado: (2020)

Identification of JAK2 and FOXM1 expression as novel candidate biomarkers for predicting the benefit of immunotherapy in lung squamous cell carcinoma
por: Zhang, Shixin, et al.
Publicado: (2021)

ALKBH family members as novel biomarkers and prognostic factors in human breast cancer
por: Chen, Hongxi, et al.
Publicado: (2022)

Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironment
por: Chen, Bowen, et al.
Publicado: (2020)

Identification of Prognostic Biomarkers for Breast Cancer Metastasis Using Penalized Additive Hazards Regression Model
por: Tapak, Leili, et al.
Publicado: (2023)

Cytochrome b561 Serves as a Potential Prognostic Biomarker and Target for Breast Cancer
por: Yang, Xiaochen, et al.
Publicado: (2021)

Comprehensive molecular biomarker identification in breast cancer brain metastases
por: Schulten, Hans-Juergen, et al.
Publicado: (2017)

Prognostic factors for breast cancer squamous cell carcinoma and nomogram development for prediction: population-based research
por: Cheng, Zhiyuan, et al.
Publicado: (2019)

Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets
por: Morera, Daley S, et al.
Publicado: (2017)

Identification of HnRNP Family as Prognostic Biomarkers in Five Major Types of Gastrointestinal Cancer
por: Chen, Xianghan, et al.
Publicado: (2022)

Cyclin genes as potential novel prognostic biomarkers and therapeutic targets in breast cancer
por: Liu, Nian-Qiu, et al.
Publicado: (2022)

Identification of Novel Molecular Therapeutic Targets and Their Potential Prognostic Biomarkers Based on Cytolytic Activity in Skin Cutaneous Melanoma
por: Zhang, Haoxue, et al.
Publicado: (2022)

Identification of miR-320 family members as potential diagnostic and prognostic biomarkers in myelodysplastic syndromes
por: Wan, Chengyao, et al.
Publicado: (2021)

Prognostic Impact of Src, CDKN1B, and JAK2 Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab
por: Economopoulou, Panagiota, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m9isbgpfrlidkgg51nse7atol5